NASDAQ: KYMRKymera Therapeutics Inc Stock Ownership - Who owns Kymera Therapeutics?
Insider buying vs selling
Have Kymera Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Baker Bros Advisors LP | Director | 2025-06-30 | 55,191 | $44.00 | $2.43MBuy |
| Baker Bros Advisors LP | Director | 2025-06-30 | 600,309 | $44.00 | $26.41MBuy |
| Bvf Partners L P | Director | 2025-06-30 | 58,780 | $44.00 | $2.59MBuy |
| Bvf Partners L P | Director | 2025-06-30 | 142,604 | $44.00 | $6.27MBuy |
| Bvf Partners L P | Director | 2025-06-30 | 115,783 | $44.00 | $5.09MBuy |
| Elena Ridloff | Director | 2025-06-11 | 4,500 | $50.00 | $225.00kSell |
| Elena Ridloff | Director | 2025-06-11 | 4,500 | $20.29 | $91.31kBuy |
| Nello Mainolfi | Chief Executive Officer | 2025-06-03 | 30,000 | $49.00 | $1.47MSell |
| Pamela Esposito | Director | 2025-06-03 | 5,000 | $49.04 | $245.19kSell |
| Pamela Esposito | Director | 2025-06-03 | 5,000 | $29.55 | $147.75kBuy |
KYMR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when KYMR insiders and whales buy or sell their stock.
KYMR Shareholders
What type of owners hold Kymera Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Price T Rowe Associates Inc | 10.29% | 6,702,450 | $302.82M | Institution |
| Avoro Capital Advisors LLC | 9.92% | 6,460,000 | $291.86M | Institution |
| Baker Bros Advisors LP | 9.39% | 6,117,295 | $276.38M | Insider |
| Wellington Management Group LLP | 9.21% | 5,996,873 | $270.94M | Institution |
| Baker Bros Advisors LP | 9.21% | 5,995,929 | $270.90M | Institution |
| Atlas Venture Associates X LP | 8.85% | 5,763,012 | $260.37M | Insider |
| Atlas Venture Fund X LP | 8.45% | 5,504,905 | $248.71M | Insider |
| Vanguard Group Inc | 8.03% | 5,231,392 | $236.35M | Institution |
| Bvf Inc | 7.93% | 5,161,801 | $233.21M | Institution |
| Atlas Venture Life Science Advisors LLC | 7.52% | 4,896,462 | $221.22M | Institution |
KYMR vs Biotech Stocks
Kymera Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.